Vancomycin

"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.

Descriptor ID	D014640
MeSH Number(s)	D09.400.420.925 D12.644.233.925
Concept/Terms	Vancomycin Vancomycin Vancomycin Hydrochloride Vancomycin Hydrochloride Hydrochloride, Vancomycin Vancomycin Sulfate Vancomycin Sulfate Sulfate, Vancomycin Vancomycin-ratiopharm Vancomycin-ratiopharm Vancomycin Hexal Vancomycin Hexal Vancomycine Dakota Vancomycine Dakota AB-Vancomycin AB-Vancomycin Vanco Azupharma Vanco Azupharma Diatracin Diatracin VANCO-cell VANCO-cell Vanco-saar Vanco-saar Vancocin Vancocin Vancocin HCl Vancomycin Lilly Vancocine Vancomicina Abbott Vancomicina Abbott Vancomicina Chiesi Vancomicina Chiesi Vancomicina Combino Phar Vancomicina Combino Phar Vancomicina Norman Vancomicina Norman Vancomycin Phosphate (1:2) Vancomycin Phosphate (1:2) Vancomycin Phosphate (1:2), Decahydrate Vancomycin Phosphate (1:2), Decahydrate

Below are MeSH descriptors whose meaning is more general than "Vancomycin".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycoconjugates [D09.400]
Glycopeptides [D09.400.420]
Vancomycin [D09.400.420.925]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Glycopeptides [D12.644.233]
Vancomycin [D12.644.233.925]

Below are MeSH descriptors whose meaning is related to "Vancomycin".

Below are MeSH descriptors whose meaning is more specific than "Vancomycin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.

Bar chart showing 107 publications over 29 distinct years, with a maximum of 8 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	2	1	3
1996	1	3	4
1997	0	1	1
1999	2	1	3
2000	0	2	2
2002	0	4	4
2003	1	0	1
2004	1	1	2
2005	1	1	2
2006	0	1	1
2007	5	2	7
2008	2	3	5
2009	3	4	7
2010	6	1	7
2011	1	3	4
2012	5	2	7
2013	3	3	6
2014	3	5	8
2015	6	1	7
2016	0	2	2
2017	5	2	7
2018	1	1	2
2019	1	1	2
2020	2	2	4
2021	3	1	4
2022	0	2	2
2023	0	1	1
2024	1	0	1
2025	1	0	1

Below are the most recent publications written about "Vancomycin" by people in Profiles.

Delaney LJ, Machado P, Liu JB, Evans R, Winslow A, Zhao N, Kepler CK, Narayanan R, Ezeonu T, Soni V, Kaushal G, Hilliard R, Schaer TP, Hickok NJ, Forsberg F. Ultrasound-triggered release of vancomycin from a novel spinal device: Antibiotic release and efficacy in vivo. Int J Pharm. 2025 Feb 25; 671:125276.

View in: PubMed
Mulpur P, Jayakumar T, Yakkanti RR, Apte A, Hippalgaonkar K, Annapareddy A, Masilamani ABS, Reddy AVG. Efficacy of Intrawound Vancomycin in Prevention of Periprosthetic Joint Infection After Primary Total Knee Arthroplasty: A Prospective Double-Blinded Randomized Control Trial. J Arthroplasty. 2024 Jun; 39(6):1569-1576.

View in: PubMed
Ma C, McCallen J, McVey JC, Trehan R, Bauer K, Zhang Q, Ruf B, Wang S, Lai CW, Trinchieri G, Berzofsky JA, Korangy F, Greten TF. CSF-1R+ Macrophages Control the Gut Microbiome-Enhanced Liver Invariant NKT Function through IL-18. J Immunol. 2023 10 01; 211(7):1099-1107.

View in: PubMed
Chiotos K, Fitzgerald JC, Hayes M, Dashefsky H, Metjian TA, Woods-Hill C, Biedron L, Stinson H, Ku BC, Robbins Tighe S, Weiss SL, Balamuth F, Schriver E, Gerber JS. Improving Vancomycin Stewardship in Critically Ill Children. Pediatrics. 2022 04 01; 149(4).

View in: PubMed
Patel D, Patel SN, Chaudhary V, Garg SJ. Complications of intravitreal injections: 2022. Curr Opin Ophthalmol. 2022 May 01; 33(3):137-146.

View in: PubMed
Lanata MM, Diaz A, Hecht SM, Katragkou A, Gallup N, Buckingham DA, Tansmore JL, Sargel C, Watson JR, Karsies T. Empiric Vancomycin Reduction in a Pediatric Intensive Care Unit. Pediatrics. 2021 09; 148(3).

View in: PubMed
Deneau MR, Mack C, Mogul D, Perito ER, Valentino PL, Amir AZ, DiGuglielmo M, Draijer LG, El-Matary W, Furuya KN, Gupta N, Hochberg JT, Horslen S, Jensen MK, Jonas MM, Kerkar N, Koot BGP, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mohammad S, Ovchinsky N, Rao G, Ricciuto A, Sathya P, Schwarz KB, Shah U, Singh R, Vitola B, Zizzo A, Guthery SL. Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis. Hepatology. 2021 03; 73(3):1061-1073.

View in: PubMed
Aderman CM, Chao DL, Obeid A, Schwartz DM, Bhisitkul RB, Chiu CS. BILATERAL ENTEROCOCCUS FAECALIS ENDOPHTHALMITIS WITH MULTIPLE RECURRENCES. Retin Cases Brief Rep. 2021 Jan 01; 15(1):38-42.

View in: PubMed
Peck TJ, Patel SN, Ho AC. Endophthalmitis after cataract surgery: an update on recent advances. Curr Opin Ophthalmol. 2021 Jan; 32(1):62-68.

View in: PubMed
Kalbian I, Park JW, Goswami K, Lee YK, Parvizi J, Koo KH. Culture-negative periprosthetic joint infection: prevalence, aetiology, evaluation, recommendations, and treatment. Int Orthop. 2020 07; 44(7):1255-1261.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement